Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Menorrhagia (heavy menstrual bleeding) - How up-to-date is this topic?
Changes

Version 1.5, revision planned in 2011.

Last revised in October 2010

January 2011 — correction to the dosage and usage instructions for tranexamic acid. Prescription also corrected. Issued in January 2011.

October 2010 — topic structure revised to ensure consistency across CKS topics — no changes to clinical recommendations have been made.

September 2010 — minor update. A prescription for Rigevidon®, another new ethinylestradiol plus levonorgestrel combined oral contraceptive pill, has been added. Issued in September 2010.

June 2010 — minor update. A prescription for Levest®, a new ethinylestradiol plus levonorgestrel combined oral contraceptive pill, has been added. Issued in June 2010.

February 2009 — minor update to the combined oral contraceptive pill prescriptions. The upper age limit for use has been reduced to 50 years. Issued in March 2009.

June to September 2007 — converted from PRODIGY guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence.

The most important change to the recommendations is that the levonorgestrel-releasing intrauterine system is now recommended first-line for most women with heavy menstrual bleeding.

© NHS Institute for Innovation and Improvement